GENE ONLINE|News &
Opinion
Blog

Geneonline AI
Study Finds ADHD Prevalence Unchanged Amid Ongoing Medication Shortages
2025-06-18
FDA Panel Discusses Streamlining Drug Approvals for Rare Disease Therapies
2025-06-18
SCHOTT Pharma Allocates €100 Million to Boost RTU Sterile Cartridge Production Capacity
2025-06-18
European Commission Approves Fixed-Duration Regimen of Calquence and Venetoclax for Chronic Lymphocytic Leukemia
2025-06-18
Alvotech and Dr. Reddy’s Partner to Develop Biosimilar for Cancer Drug Pembrolizumab
2025-06-18
Atopic Dermatitis Market in Seven Major Global Regions Projected to Reach $22.4 Billion by 2033
2025-06-18
Servier India Launches Ivosidenib for AML and Cholangiocarcinoma Patients with IDH1 Mutation Following CDSCO Approval
2025-06-18
ASPA and CRISIL to Release 2025 Report Evaluating Counterfeiting Risks Across Key Indian Sectors
2025-06-18
LYT-100 Investigational Drug Explored as Alternative for Idiopathic Pulmonary Fibrosis Treatment
2025-06-18
Saloni Wagh and Shivani Wagh of Supriya Lifescience Featured in 2025 Candere Hurun India Women Leaders List Amid Record Fiscal Revenue
2025-06-18
Lupin Secures US FDA Tentative Approval for Oxcarbazepine ER Tablets Manufactured in Nagpur
2025-06-18
Global Pharmaceutical Sector Records $6.96 Billion in May 2025 Deal Activity with Three Major Agreements Driving 59 Percent of M&A Value
2025-06-18
Eli Lilly Acquires SiteOne Therapeutics to Develop Non-Opioid Pain Treatment STC-004
2025-06-18
New Device Promises to Streamline CAR T-Cell Therapy Production for Earlier Cancer Treatment
2025-06-18
Roche Reports Near-Complete Suppression of Disability Progression in RMS Patients Over Two Years with BTK Inhibitor
2025-06-18
1 2 3 507
LATEST
FDA Panel Discusses Streamlining Drug Approvals for Rare Disease Therapies
2025-06-18
SCHOTT Pharma Allocates €100 Million to Boost RTU Sterile Cartridge Production Capacity
2025-06-18
European Commission Approves Fixed-Duration Regimen of Calquence and Venetoclax for Chronic Lymphocytic Leukemia
2025-06-18
Alvotech and Dr. Reddy’s Partner to Develop Biosimilar for Cancer Drug Pembrolizumab
2025-06-18
Atopic Dermatitis Market in Seven Major Global Regions Projected to Reach $22.4 Billion by 2033
2025-06-18
Servier India Launches Ivosidenib for AML and Cholangiocarcinoma Patients with IDH1 Mutation Following CDSCO Approval
2025-06-18
ASPA and CRISIL to Release 2025 Report Evaluating Counterfeiting Risks Across Key Indian Sectors
2025-06-18
EVENT
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top